ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,432, issued on April 29, was assigned to OcuTerra Therapeutics Inc. (Boston).
"Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof" was invented by Ben C. Askew (Marshfield, Mass.) and Takeru Furuya (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to fluorinated compounds of formula I and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing the fluorinated compounds of the invention, and methods of treating fibrosis, macular degeneration, diabetic retinopathy (DR), macular edema, diabetic macular edema (DME), and ...